CANADA LIFE ASSURANCE Co
InsurancePosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1046192
WINNIPEG, A2
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$90,586,166
+$4,786,185 QoQ
Shares Held
182,365
-5.1% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#118
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. VRTX ranks #1 (27.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,586,166 | 182,365 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $85,799,981 | 192,144 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $85,052,149 | 187,604 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $107,362,623 | 274,136 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $120,520,981 | 270,712 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $131,252,409 | 270,724 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $108,679,870 | 269,878 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $148,026,127 | 318,281 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $150,123,516 | 320,284 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $112,955,498 | 270,222 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $113,338,802 | 278,549 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $98,628,105 | 283,626 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $98,826,181 | 280,828 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $86,221,110 | 273,657 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $80,374,404 | 278,324 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $86,351,830 | 298,238 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $84,383,988 | 299,457 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $104,465,247 | 400,296 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $89,074,591 | 405,622 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $70,667,185 | 389,587 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $78,348,578 | 388,576 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $61,254,824 | 285,052 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $79,974,855 | 338,389 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $85,718,886 | 315,004 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $84,035,744 | 289,469 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $62,753,125 | 263,724 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||